Evidence map›Paper›PMID 36187516›Full record

ArticleIndian journal of surgical oncology2022

Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study.

Khaled Gaballa, Islam H Metwally, Basel Refky, Shadi Awny, Mohamed Abdelkhalek, Mohamed Hamdy

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Khaled GaballaSurgical Oncology Department, Oncology Center, Mansoura University (OCMU), Geehan Street, Mansoura, 35516 Dakahlia Egypt.
Islam H MetwallySurgical Oncology Department, Oncology Center, Mansoura University (OCMU), Geehan Street, Mansoura, 35516 Dakahlia Egypt.
Basel RefkySurgical Oncology Department, Oncology Center, Mansoura University (OCMU), Geehan Street, Mansoura, 35516 Dakahlia Egypt.
Shadi AwnySurgical Oncology Department, Oncology Center, Mansoura University (OCMU), Geehan Street, Mansoura, 35516 Dakahlia Egypt.
Mohamed AbdelkhalekSurgical Oncology Department, Oncology Center, Mansoura University (OCMU), Geehan Street, Mansoura, 35516 Dakahlia Egypt.
Mohamed HamdySurgical Oncology Department, Oncology Center, Mansoura University (OCMU), Geehan Street, Mansoura, 35516 Dakahlia Egypt.
Mansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity has long been associated with endometrial cancer. However, there is a paucity of studies addressing the impact of morbid obesity in type II endometrial cancer on oncologic and surgical outcomes. In this study, the author retrospectively compared morbid to non-morbid obese in clinico-epidemiologic, surgical, and oncologic outcomes. Both groups were comparable as regards all clinico-epidemiologic parameters. Vaginal involvement, survival, and recurrence were also comparable between the 2 groups. Para-aortic adenopathy and treatment with preoperative therapy were the only significant predictors of DFS. Surgery is feasible with equivalent complications and oncologic outcomes in morbidly obese patients with type II endometrial cancer.

Indexed as

Endometrial cancerHysterectomyObesity Non-endometrioid carcinoma

Identifiers

PMID36187516
PMCPMC9515259
OpenAlexW4206418720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.